Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut AllergyMatthew Greenhawt, Paul Turner, Philippe Bégin et al.|New England Journal of Medicine|2023Cited by 129
FGF10 Signaling differences between type I pleuropulmonary blastoma and congenital cystic adenomatoid malformationGuillaume Lezmi, Christophe Delacourt|Orphanet Journal of Rare Diseases|2013Cited by 72
Congenital cystic adenomatoid malformations of the lung: an epithelial transcriptomic approachGuillaume Lezmi, Christophe Delacourt|Respiratory Research|2020Cited by 66
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPEMatthew Greenhawt, Christian Vogelberg, Deborah Albright et al.|The Journal of Allergy and Clinical Immunology In Practice|2025Cited by 14
Restored Cytokine-Producing Capacities of Mucosal-associated Invariant T Cells in Pediatric Cystic Fibrosis Patients Treated with Elexacaftor/Tezacaftor/IvacaftorEmmanuelle Bardin, Maria Leite‐de‐Moraes, Céline Dietrich et al.|American Journal of Respiratory and Critical Care Medicine|2024Cited by 2